Highlights
Advances in Genome Biology and Technology Meeting 2012
The Advances in Genome Biology and Technology (AGBT) meeting is an annual scientific forum for acquiring information about the latest advances in DNA sequencing technologies and applications.
New Drug Target for Childhood Eye Tumor
New findings from the St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project (PCGP) have helped identify the mechanism that makes the childhood eye tumor retinoblastoma so aggressive.
Progress in Fight Against Aggressive Childhood Leukemia
A new study provides the first details of the genetic alterations fueling a subtype of acute lymphoblastic leukemia (ALL), a childhood cancer with a poor prognosis.
Chemotherapy May Influence Leukemia Relapse
Research from The Genome Institute and colleagues suggests chemotherapy may contribute to relapse in some patients with acute myeloid leukemia.
Sequencing the House Cat
Domesticated cats are the most popular pets globally, with approximately 34% of households owning over 88 million cats in the US alone. The cat is an important model organism for biomedical research and it is used in understanding mammalian development, cancer and infectious disease research.
The Genome Institute Receives Four-Year $114 million Grant
Washington University's Genome Institute has received a $114 million four-year grant from the National Human Genome Research Institute (NHGRI) to continue its groundbreaking genomic research.
Sequencing the Atlantic Killifish
The Genome Institute is collaborating on a project to sequence the Atlantic Killifish and identify the genes it has evolved to help it survive in extreme conditions.
American Bald Eagle Sequenced
Researchers at The Genome Institute in collaboration with Dr. Erich Jarvis, Duke University, have sequenced the genome of the American bald eagle – the symbol of the United States of America.
Global Health Genomics: Battling Pneumonia in the Gambia
The Genome Institute is collaborating with researchers in the Gambia to understand what makes a type of bacteria that causes pneumonia so deadly and how its vaccine affects the microbial populations that colonize infants.
Komen Research Advocacy Genomics Training Event
On April 16 a group of women from the Komen St. Louis Research Advocacy Committee joined together at The Genome Institute to learn about genomics and breast cancer. The event gave the committee members an opportunity to learn about the latest in genomic research and understand more about how this emerging field is affecting clinical breast cancer research.
